Established in 2002, the HERA Women’s Cancer Foundation is a 501(c)(3) non-profit organization whose mission is to stop the loss of women from ovarian cancer by promoting Health, Empowerment, Research, and Awareness. As a nationally recognized ovarian cancer organization, HERA provides funding for cutting-edge research grants to scientists at respected medical institutions. In so doing, HERA attracts more young researchers to expand the scientific understanding of ovarian cancer while improving the lives of those battling the disease. HERA also embraces projects related to raising awareness about ovarian cancer and its symptoms in different communities around the country. By stressing the concept of “community,” HERA supports and empowers those undergoing treatment for ovarian cancer, as well as women who are healthy.
In 2011, HERA invested 88% of the funds raised via its signature Climb4LifeSM rock climbing & hiking weekends in programs that continue to provide research, awareness, education and community support. In brief, the HERA Women’s Cancer Foundation aspires to continually expand its sphere of influence and touch the lives of all those affected by ovarian cancer.
Click here to access the HERA Mother’s Day 5K fundraising page
About Ovarian Cancer
One in 71 women will be diagnosed with ovarian cancer in her lifetime. It affects mothers, daughters, sisters and friends. With early detection about 94% will survive longer than 5 years after diagnosis, but currently, only 15% of ovarian cancer is caught early. It ranks fifth as the cause of cancer deaths in women, and accounts for more deaths than any other cancer of the female reproductive system. Estimates for ovarian cancer in the United States for 2012: about 22,280 new cases of ovarian cancer will be diagnosed and about 15,500 deaths will occur.
HERA awards grants annually to scientists with “outside the box” ideas regarding new directions in the basic research, treatment, early detection, and prevention of ovarian cancer. These “OSB” grants have been awarded to researchers at such prestigious institutions as Johns Hopkins University in Baltimore, Maryland and the M.D. Anderson Cancer Center at the University of Texas in Houston. Additionally, the Sean Patrick Multidisciplinary Collaborative Grant provides an award for a cross-disciplinary project that is collaborative in nature. The award is given to two (or more) scientists with different yet complementary skills whose work will be synergistic in addressing the ovarian cancer problem. The University of Colorado School of Medicine received the first Sean Patrick Multidisciplinary Collaborative Grant in 2011. The 2012 award was shared by the University of Chicago and the University of Texas.
Currently no effective test exists to reliably diagnose the disease early when the chance for survival is greatest. Our priority is to understand this disease so that a test for early detection and more effective treatments can be developed.
HERA provides support for non-profit ovarian cancer community groups across the country to improve the quality-of-life for women with ovarian cancer or raise awareness about the disease in novel and unusual ways. In 2012, grants were awarded to the Ovarian Cancer Summit in Denver, CO; Teal Toes in Bethesda, MD; the Mautner Project in Washington, DC; and, the Women’s Cancer Awareness Group in Petaluma, CA.
Since 2002, HERA has awarded $822,750 for scientific research and community grants.